Abstract:Background: The overall objective of the present study is to extend our understanding of the clinical phenotype and underlying mechanism of a newly discovered cardiac arrhythmia syndrome through a multicenter study. Gain-of-function mutations in the cardiac Ca 2+ release channel (RyR2 [ryanodine receptor 2]) cause catecholaminergic polymorphic ventricular tachycardia, whereas loss-of-function RyR2 mutations are linked to a new cardiac arrhythmia disorder termed Ca 2+ -release deficiency syndrome (CRDS). Catecholaminergic polymorphic ventricular tachycardia is an inherited arrhythmia disorder characterized by stress-induced bidirectional and polymorphic ventricular tachyarrhythmias and is routinely diagnosed by using exercise stress testing. Conversely, RyR2-CRDS is characterized by ventricular arrhythmias and sudden cardiac death but a negative exercise stress testing for catecholaminergic polymorphic ventricular tachycardia. There are currently no clinical diagnostic tests for CRDS and affected patients may manifest with sudden cardiac death as their first symptom. In the absence of effective clinical diagnostic tools, in vitro functional characterization of associated RyR2 mutations provides an alternative means to identify potential cases of CRDS. Methods: We searched for patients presenting with phenotypes compatible with CRDS that have RyR2 mutations and performed in vitro functional characterization. Results: We found that 3 novel (G570D, R4147K, and A4203V) and 2 previously reported (M4109R and A4204V) RyR2 mutations associated with CRDS phenotypes markedly reduced caffeine-induced Ca 2+ release and store overload-induced Ca 2+ release. We also characterized 2 additional loss-of-function RyR2 mutations previously reported (Q3925E and L4769S) that are located in the central and channel pore-forming domains critical for Ca 2+ activation and channel gating. Q3925E was identified through postmortem genetic testing in an individual who died suddenly, while L4769S is a variant of uncertain significance reported in ClinVar, suggesting that RyR2 CRDS may be under detected. Conclusions: These findings provide further support for the existence of an emerging RyR2 loss-of-function associated arrhythmia syndrome (CRDS) and shed new insights into the disease mechanism.

Attempts to Create Transgenic Mice Carrying the Q3924E Mutation in RyR2 Ca2+ Binding Site

Enhanced Basal Activity of a Cardiac Ca2+ Release Channel (ryanodine Receptor) Mutant Associated with Ventricular Tachycardia and Sudden Death.

Loss of Luminal Ca 2+ Activation in the Cardiac Ryanodine Receptor is Associated with Ventricular Fibrillation and Sudden Death

Characterization of a Novel Mutation in the Cardiac Ryanodine Receptor That Results in Catecholaminergic Polymorphic Ventricular Tachycardia

RyR 2 Mutations Linked to Ventricular Tachycardia and Sudden Death Reduce the Threshold for Store-Overload-induced Ca 2 Release ( SOICR )

Identification of RyR2-PBmice and the Effects of Transposon Insertional Mutagenesis of the RyR2 Gene on Cardiac Function in Mice.

Endoplasmic Reticulum Ca2+ Measurements Reveal That the Cardiac Ryanodine Receptor Mutations Linked to Cardiac Arrhythmia and Sudden Death Alter the Threshold for Store-Overload-induced Ca2+ Release.

Cardiac Hypertrophy and Arrhythmia in Mice Induced by a Mutation in Ryanodine Receptor 2

Arrhythmogenic mechanism of a novel ryanodine receptor mutation underlying sudden cardiac death

Novel Ryanodine Receptor Mutation Associated With Hypertrophic Cardiomyopathy Induces Cardiac Remodeling and Arrhythmia in Mice

Abstract 16920: Permanent Reduction of Ryr2 Improves Lv Ejection Fraction in Heart Failure

Modeling of Transgenic Mice Cardiac- Specifically Overexpressing Human KCNE4 Gene

Human RyR2 (ryanodine Receptor 2) Loss-of-Function Mutations

A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9

Abnormal Ca2+ Homeostasis, Atrial Arrhythmogenesis, and Sinus Node Dysfunction in Murine Hearts Modeling RyR2 Modification

Atrial Arrhythmia, Triggering Events and Conduction Abnormalities in Isolated Murine Ryr2-P2328s Hearts

Increased Ca2+ Transient Underlies RyR2-Related Left Ventricular Noncompaction

Long-term efficacy and safety of cardiac genome editing for catecholaminergic polymorphic ventricular tachycardia

Dose-Dependent Arrhythmia and Cardiac Dysfunction in Restrictive Cardiomyopathy Mice Due to Troponin Mutations

Abstract 13431: Gain-of-Function Mutations in RNA Binding Motif 20 Result in Cardiac Remodelling and Pathogenesis in Mice

Cardiac RNase Z edited via CRISPR-Cas9 drives heart hypertrophy in Drosophila